Ventes Changement Date
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amgen USD 10.4B 300M 2026-09
Arrowhead Research USD 450.82M 375.59M 2026-09
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Moderna USD 1.31M 98.69M 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 14.52B 112M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09